国家神经系统疾病临床医学研究中心数据管理与共享系统

发表杂志：Current Cardiology Reports

发表类型: Original Contributions

影响因子(IF): 2.931

PMID: 26294261 Pubmed原文链接 全文下载

Stroke is a major public health concern worldwide, and 25 % of stroke victims would have another stroke. Although administration of antiplatelet agents has been confirmed to be one of the major approaches for secondary prevention of noncardioembolic stroke, the short-term or long-term use of aspirin plus clopidogrel for secondary stroke prevention remains to be controversial. This article aims at providing a comprehensive review of the evidence on the use of aspirin plus clopidogrel for secondary stroke prevention, with special focus on important studies that may impact clinical practice of treating patients with stroke or transient ischemic attack.